Literature DB >> 18413880

Impugning the integrity of medical science: the adverse effects of industry influence.

Catherine D DeAngelis, Phil B Fontanarosa.   

Abstract

Mesh:

Year:  2008        PMID: 18413880     DOI: 10.1001/jama.299.15.1833

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  47 in total

1.  Misconduct versus honest error and scientific disagreement.

Authors:  David B Resnik; C Neal Stewart
Journal:  Account Res       Date:  2012       Impact factor: 2.622

2.  [Medicalisation of prevention: notes on procedures, contents and basics].

Authors:  Félix Miguel García; Alejandro Merino Senovilla; Ruperto Sanz Cantalapiedra; Alejandra García Ortiz; María José Montero Alonso; José Angel Maderuelo Fernández
Journal:  Aten Primaria       Date:  2009-05-30       Impact factor: 1.137

3.  Scientific self-regulation-so good, how can it fail? Commentary on "The problems with forbidding science".

Authors:  Patrick L Taylor
Journal:  Sci Eng Ethics       Date:  2009-04-10       Impact factor: 3.525

Review 4.  When drug companies select what they want to publish patients are denied relevant therapeutic information.

Authors:  Graziella Filippini; Lorenzo Moja; Alessandro Liberati; Gian Franco Gensini; Roberto Gusinu; Andrea A Conti
Journal:  Intern Emerg Med       Date:  2008-09       Impact factor: 3.397

5.  Responding to the American siege against continuing medical education.

Authors:  George D Lundberg
Journal:  Medscape J Med       Date:  2008-06-13

6.  Let's get real about conflicts of interest in medicine.

Authors:  John F Kamp
Journal:  Medscape J Med       Date:  2008-06-09

7.  The quest for a meaningful evidence base in psychiatry.

Authors:  Robin Emsley; Sue Hawkridge
Journal:  World Psychiatry       Date:  2009-02       Impact factor: 49.548

Review 8.  The financing of drug trials by pharmaceutical companies and its consequences: part 2: a qualitative, systematic review of the literature on possible influences on authorship, access to trial data, and trial registration and publication.

Authors:  Gisela Schott; Henry Pachl; Ulrich Limbach; Ursula Gundert-Remy; Klaus Lieb; Wolf-Dieter Ludwig
Journal:  Dtsch Arztebl Int       Date:  2010-04-30       Impact factor: 5.594

9.  Neuropsychiatric clinical trials: should they accommodate real-world practices or set standards for clinical practices?

Authors:  Robert E Becker; Nigel H Greig
Journal:  J Clin Psychopharmacol       Date:  2009-02       Impact factor: 3.153

10.  Appropriateness of collaborations between industry and the medical profession: physicians' perceptions.

Authors:  Joseph S Ross; Salomeh Keyhani; Deborah Korenstein
Journal:  Am J Med       Date:  2009-10       Impact factor: 4.965

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.